Profund Advisors LLC Chemo Centryx, Inc. Transaction History

Profund Advisors LLC

$2.59 Billion
Q3 2024

Shares

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2022 Nov 04, 2022	BUY	$22.17 - $51.8 $121,048 - $282,828	5,460 New	5,460 $282,000
Q2 2021 Aug 12, 2021	SELL	$9.59 - $50.88 $45,936 - $243,715	-4,790 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$49.53 - $68.4 $14,413 - $19,904	291 Added 6.47%	4,790 $245,000
Q4 2020 Feb 09, 2021	BUY	$47.25 - $65.16 $11,387 - $15,703	241 Added 5.66%	4,499 $279,000
Q3 2020 Nov 13, 2020	BUY	$46.35 - $61.69 $197,358 - $262,676	4,258 New	4,258 $233,000

Others Institutions Holding CCXI

# of Institutions

6

Shares Held

66.3K

Call Options Held

0

Put Options Held

0

About ChemoCentryx, Inc.

Ticker CCXI
Exchange NASDAQ
Shares Outstandng 71,919,696
Market Cap $3.68M
Description
ChemoCentryx, Inc., a biopharmaceutical company, focuses on the development and commercialization of new medications for inflammatory disorders, autoimmune diseases, and cancer in the United States. It offers TAVNEOS (avacopan), an orally administered selective C5aR inhibitor for the treatment of adult patients with severe active anti-neutrophil...

More about CCXI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Profund Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Profund Advisors LLC with notifications on news.